Blocking of CDC25B suppresses sarcoma progression via arresting cell cycle

Renqin Lin1,2,3, Jianhua Lin1,2,3

  • 1Department of Orthopedics, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.

PubMed
Abstract

Insights

Cell division cycle protein 25B (CDC25B) is overexpressed in soft tissue sarcoma, correlating with poorer survival. Inhibiting CDC25B suppresses sarcoma progression by inducing cell cycle arrest, suggesting it as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Soft tissue sarcoma is a rare malignancy originating from mesenchymal tissue.
  • The role of Cell Division Cycle Protein 25B (CDC25B) in sarcoma pathogenesis is not well understood.
  • CDC25B is implicated in various human diseases, highlighting its potential relevance in cancer.

Purpose of the Study:

  • To investigate the prognostic significance of CDC25B in sarcoma.
  • To explore the therapeutic potential of targeting CDC25B in sarcoma.
  • To elucidate the mechanism by which CDC25B influences sarcoma progression.

Main Methods:

  • Bioinformatic analysis of CDC25B expression and its correlation with survival outcomes in sarcoma.
  • In vitro experiments using a CDC25B inhibitor (CDC25B-IN-1) to assess its effects on sarcoma cells.
  • Assays included CCK-8, qPCR, EdU, colony formation, transwell migration, wound healing, flow cytometry, and Western blot.

Main Results:

  • CDC25B was found to be overexpressed in sarcoma tissues.
  • High CDC25B expression was significantly associated with decreased disease-specific survival, progress-free interval, and overall survival.
  • Inhibition of CDC25B suppressed sarcoma cell proliferation, migration, and induced G2 cell cycle arrest, confirming its role in progression.

Conclusions:

  • CDC25B is an independent prognostic biomarker for sarcoma.
  • Targeting CDC25B with inhibitors presents a promising therapeutic strategy for sarcoma.
  • CDC25B's role in cell cycle regulation offers a mechanistic basis for its therapeutic targeting in sarcoma.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.0K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.0K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K